Intravenous injection of OXA/Fe NPs in a CT26 tumor xenograft model followed by low-dose X-ray irradiation resulted in the effective regression of both primary and abscopal tumors, with heightened CRT exposure in excised primary tumor and superior CD8+ T cell activity in the abscopal tumors. The gene discussed is CALR; the disease is neoplasm.